RSV monoclonal antibody nirsevimab 83% effective in babies
NIAID/ Flickr CC The New England Journal of Medication has printed outcomes of a randomized managed trial exhibiting an estimated effectiveness of nirsevimab (Beyfortus) towards hospitalization ...
